Annual Book Value
$3.74 B
+$3.65 B+21.11%
31 December 2023
Summary:
Jazz Pharmaceuticals annual book value is currently $3.74 billion, with the most recent change of +$3.65 billion (+21.11%) on 31 December 2023. During the last 3 years, it has risen by +$77.25 million (+2.11%). JAZZ annual book value is now -5.75% below its all-time high of $3.97 billion, reached on 31 December 2021.JAZZ Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Book Value
$4.17 B
+$408.47 M+10.86%
30 September 2024
Summary:
Jazz Pharmaceuticals quarterly book value is currently $4.17 billion, with the most recent change of +$408.47 million (+10.86%) on 30 September 2024. Over the past year, it has increased by +$681.69 million (+19.54%). JAZZ quarterly book value is now at all-time high.JAZZ Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Book Value Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +21.1% | +19.5% |
3 y3 years | +2.1% | +5.9% |
5 y5 years | +35.5% | +36.6% |
JAZZ Book Value High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -5.8% | +21.1% | at high | +51.9% |
5 y | 5 years | -5.8% | +35.5% | at high | +51.9% |
alltime | all time | -5.8% | +2219.7% | at high | +2465.9% |
Jazz Pharmaceuticals Book Value History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $4.17 B(+10.9%) |
June 2024 | - | $3.76 B(+1.8%) |
Mar 2024 | - | $3.70 B(-1.1%) |
Dec 2023 | $3.74 B(+21.1%) | $3.74 B(+7.1%) |
Sept 2023 | - | $3.49 B(-1.0%) |
June 2023 | - | $3.53 B(+5.7%) |
Mar 2023 | - | $3.34 B(+8.1%) |
Dec 2022 | $3.09 B(-22.2%) | $3.09 B(+12.4%) |
Sept 2022 | - | $2.75 B(-14.2%) |
June 2022 | - | $3.20 B(-11.3%) |
Mar 2022 | - | $3.61 B(-9.0%) |
Dec 2021 | $3.97 B(+8.3%) | $3.97 B(+0.7%) |
Sept 2021 | - | $3.94 B(-4.7%) |
June 2021 | - | $4.13 B(+8.8%) |
Mar 2021 | - | $3.80 B(+3.8%) |
Dec 2020 | $3.66 B(+17.6%) | $3.66 B(+8.4%) |
Sept 2020 | - | $3.38 B(+7.5%) |
June 2020 | - | $3.14 B(+11.9%) |
Mar 2020 | - | $2.81 B(-9.7%) |
Dec 2019 | $3.11 B(+12.8%) | $3.11 B(+1.9%) |
Sept 2019 | - | $3.05 B(+2.4%) |
June 2019 | - | $2.98 B(+9.3%) |
Mar 2019 | - | $2.73 B(-1.0%) |
Dec 2018 | $2.76 B(+1.6%) | $2.76 B(-8.9%) |
Sept 2018 | - | $3.03 B(+5.5%) |
June 2018 | - | $2.87 B(+3.0%) |
Mar 2018 | - | $2.79 B(+2.7%) |
Dec 2017 | $2.71 B(+44.5%) | $2.71 B(+9.9%) |
Sept 2017 | - | $2.47 B(+12.2%) |
June 2017 | - | $2.20 B(+10.9%) |
Mar 2017 | - | $1.98 B(+5.7%) |
Dec 2016 | $1.88 B(+17.4%) | $1.88 B(+9.4%) |
Sept 2016 | - | $1.72 B(+1.4%) |
June 2016 | - | $1.69 B(+5.3%) |
Mar 2016 | - | $1.61 B(+0.6%) |
Dec 2015 | $1.60 B | $1.60 B(+2.3%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2015 | - | $1.56 B(+8.1%) |
June 2015 | - | $1.45 B(+10.8%) |
Mar 2015 | - | $1.31 B(-4.8%) |
Dec 2014 | $1.37 B(+5.8%) | $1.37 B(+2.3%) |
Sept 2014 | - | $1.34 B(+4.8%) |
June 2014 | - | $1.28 B(+2.5%) |
Mar 2014 | - | $1.25 B(-3.6%) |
Dec 2013 | $1.30 B(+15.5%) | $1.30 B(+4.2%) |
Sept 2013 | - | $1.24 B(+5.8%) |
June 2013 | - | $1.18 B(+1.2%) |
Mar 2013 | - | $1.16 B(+3.6%) |
Dec 2012 | $1.12 B(+481.6%) | $1.12 B(+26.5%) |
Sept 2012 | - | $886.09 M(+6.6%) |
June 2012 | - | $831.46 M(+6.3%) |
Mar 2012 | - | $781.83 M(+305.5%) |
Dec 2011 | $192.79 M(+531.0%) | $192.79 M(+36.4%) |
Sept 2011 | - | $141.33 M(+39.1%) |
June 2011 | - | $101.60 M(+69.1%) |
Mar 2011 | - | $60.07 M(+96.6%) |
Dec 2010 | $30.55 M(-141.9%) | $30.55 M(-287.4%) |
June 2010 | - | -$16.30 M(-76.4%) |
Mar 2010 | - | -$69.00 M(-5.3%) |
Dec 2009 | -$72.83 M(-21.6%) | -$72.83 M(-11.7%) |
Sept 2009 | - | -$82.44 M(-7.3%) |
June 2009 | - | -$88.90 M(-3.7%) |
Mar 2009 | - | -$92.30 M(-0.6%) |
Dec 2008 | -$92.88 M(-268.9%) | -$92.88 M(+143.3%) |
Sept 2008 | - | -$38.18 M(+7.2%) |
June 2008 | - | -$35.62 M(-386.3%) |
Mar 2008 | - | $12.44 M(-77.4%) |
Dec 2007 | $54.99 M(-131.2%) | $54.99 M(-50.8%) |
Sept 2007 | - | $111.69 M(-13.5%) |
June 2007 | - | $129.08 M(+70.3%) |
Mar 2007 | - | $75.81 M(-143.0%) |
Dec 2006 | -$176.30 M(+49.1%) | -$176.30 M(+49.1%) |
Dec 2005 | -$118.25 M | -$118.25 M |
FAQ
- What is Jazz Pharmaceuticals annual book value?
- What is the all time high annual book value for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual book value year-on-year change?
- What is Jazz Pharmaceuticals quarterly book value?
- What is the all time high quarterly book value for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly book value year-on-year change?
What is Jazz Pharmaceuticals annual book value?
The current annual book value of JAZZ is $3.74 B
What is the all time high annual book value for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual book value is $3.97 B
What is Jazz Pharmaceuticals annual book value year-on-year change?
Over the past year, JAZZ annual book value has changed by +$651.26 M (+21.11%)
What is Jazz Pharmaceuticals quarterly book value?
The current quarterly book value of JAZZ is $4.17 B
What is the all time high quarterly book value for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly book value is $4.17 B
What is Jazz Pharmaceuticals quarterly book value year-on-year change?
Over the past year, JAZZ quarterly book value has changed by +$681.69 M (+19.54%)